Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized comparison of manual versus mechanical thrombus removal in primary percutaneous coronary intervention in the treatment of ST-segment elevation myocardial infarction (TREAT-MI).
Vink MA, Patterson MS, van Etten J, Ijsselmuiden AJ, Dirksen MT, Amoroso G, Slagboom T, Laarman G, Kiemeneij F. Vink MA, et al. Among authors: dirksen mt. Catheter Cardiovasc Interv. 2011 Jul 1;78(1):14-9. doi: 10.1002/ccd.22932. Catheter Cardiovasc Interv. 2011. PMID: 21681888 Clinical Trial.
The effect of ITF-1697 on reperfusion in patients undergoing primary angioplasty. Safety and efficacy of a novel tetrapeptide, ITF-1697.
Dirksen MT, Laarman G, van 't Hof AW, Guagliumi G, Tonino WA, Tavazzi L, Duncker DJ, Simoons ML; PARI-MI Investigators (Protect Against Reperfusion Injury with ITF-1697 in acute Myocardial Infarction). Dirksen MT, et al. Eur Heart J. 2004 Mar;25(5):392-400. doi: 10.1016/j.ehj.2003.12.018. Eur Heart J. 2004. PMID: 15033251 Clinical Trial.
Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI study.
Bär FW, Tzivoni D, Dirksen MT, Fernández-Ortiz A, Heyndrickx GR, Brachmann J, Reiber JH, Avasthy N, Tatsuno J, Davies M, Hibberd MG, Krucoff MW; CASTEMI Study Group. Bär FW, et al. Among authors: dirksen mt. Eur Heart J. 2006 Nov;27(21):2516-23. doi: 10.1093/eurheartj/ehl304. Epub 2006 Oct 9. Eur Heart J. 2006. PMID: 17030521 Clinical Trial.
Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
De Luca G, Stone GW, Suryapranata H, Laarman GJ, Menichelli M, Kaiser C, Valgimigli M, Di Lorenzo E, Dirksen MT, Spaulding C, Pittl U, Violini R, Percoco G, Marino P. De Luca G, et al. Among authors: dirksen mt. Int J Cardiol. 2009 Apr 3;133(2):213-22. doi: 10.1016/j.ijcard.2007.12.040. Epub 2008 Apr 3. Int J Cardiol. 2009. PMID: 18394731
Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study.
Dirksen MT, Vink MA, Suttorp MJ, Tijssen JG, Patterson MS, Slagboom T, Kiemeneij F, Laarman GJ; Paclitaxel-Eluting Stent versus Conventional Stent; in Myocardial Infarction with ST-Segment Elevation (PASSION) investigators. Dirksen MT, et al. EuroIntervention. 2008 May;4(1):64-70. doi: 10.4244/eijv4i1a12. EuroIntervention. 2008. PMID: 19112781 Clinical Trial.
59 results